15 Cryptococcus neoformans is an opportunistic human pathogen, which causes serious disease 16 in immunocompromised hosts. Infection with this pathogen is particularly relevant in HIV + 17 patients, where it leads to around 200,000 deaths per annum. A key feature of cryptococcal 18 pathogenesis is the ability of the fungus to survive and replicate within the phagosome of 19 macrophages, as well as its ability to escape via a novel non-lytic mechanism known as 20 vomocytosis. We have been exploring whether viral infection affects the interaction between 21 C. neoformans and macrophages. Here we show that viral infection enhances cryptococcal 22 vomocytosis without altering phagocytosis or intracellular proliferation of the fungus. This 23 effect occurs with distinct, unrelated human viral pathogens and is recapitulated when 24 macrophages are stimulated with the anti-viral cytokine interferon alpha (IFN). Importantly, 25 the effect is abrogated when type-I interferon signalling is blocked, thus underscoring the 2 26 importance of type-I interferons in this phenomenon. Our results highlight the importance of 27 incorporating specific context cues while studying host-pathogen interactions. By doing so, we 28 found that acute viral infection may trigger the release of latent cryptococci from intracellular 29 compartments, with significant consequences for disease progression. 30 31 Non-Technical Author Summary 32 Infectious diseases are typically studied in the laboratory in isolation, but in real life people 33 often encounter multiple infections simultaneously. Here we investigate how the innate 34 immune response to the fatal fungus Cryptococcus neoformans is influenced by viral 35 coinfection. Whilst virally-infected macrophages retain a normal capacity to engulf and kill 36 Cryptococci, they demonstrate a dramatically enhanced propensity to expel them via the 37 process known as non-lytic expulsion or vomocytosis. Activation of vomocytosis is 38 independent of the type of virus encountered, since both HIV and measles (two entirely 39 unrelated viral pathogens) trigger the same effect. Instead it is driven by interferon-, a generic 40 'antiviral' response, which signals back to the infected macrophage, triggering expulsion of the 41 fungus. We propose that this hitherto unobserved phenomenon represents a 'reprioritisation' 42 pathway for innate immune cells, by which they can alter the frequency with which they expel 43 one pathogen (Cryptococcus) depending on the level of threat from a secondary viral infection. 44 3 45 Introduction 46 47 Since their discovery in 1957 by Isaacs and Lindenmann (1), the antiviral effects of type I 48 interferons have been well documented (2-4). More recently, their roles in non-viral infections
130 Human macrophage isolation and culture 131 20-40 mL of blood were drawn from healthy donors by venepuncture. 6 mL of whole blood 132 were carefully layered on top of a double layer of Percoll (densities of 1.079 and 1.098 g/mL).
133 Samples were centrifuged in a swing bucket rotor at 150g for 8 minutes, followed by 10 134 minutes at 1200g, with acceleration and break set to zero. The resulting white disc of peripheral 135 blood mononuclear cells (PBMC) was transferred to a clean vial and incubated with red blood 136 cell lysis buffer at a ratio of 1:3 for 3 minutes, with gentle mixing throughout to prevent clot 137 formation. Cells were then washed with ice cold PBS twice, with centrifugation at 400g for 6 138 minutes in between each wash, and counted with a haemocytometer. 1x10 6 PBMC were seeded 139 onto 48-well plates in RPMI-1640 media containing 1% penicillin/streptomycin, 5% heat-140 inactivated AB human serum and 20 ng/mL M-CSF (Invitrogen). Cells were washed with PBS 141 and resuspended in fresh media on days 3 and 6 of differentiation. Macrophages were ready to 142 use on day 7. A yield of 1x10 5 macrophages per well was estimated.
144 Cryptococcus infection
145 Fungi were opsonised with 10% human AB serum or 18B7 antibody (a kind gift from Arturo 146 Casadevall) for 1 hour and then added to macrophages at a multiplicity of infection of 10:1.
147 Infection was carried out in serum free-media, at 37°C with 5% CO 2 . After 2 hours, cells were 148 washed 3 times with PBS to remove any extracellular fungi and fresh serum free-media was 149 added.
151 Drug treatments
152 Exogenous compounds were added to macrophages at two stages; when infecting with 153 Cryptococcus and again when replenishing with fresh media after removing extracellular fungi.
12 251 was particularly prominent on virally infected cells rather than neighbouring cells which were 252 not infected (Non-MeV; Figure 3B ), suggesting that the impact of IFN signalling on 253 vomocytosis is highly localised and specific to the autocrine responses occurring within 254 infected cells, rather than endocrine responses mediated through cytokines.
13 255 Discussion 256 257 In this study we set out to explore the consequences, if any, of viral infection on Cryptococcal 258 infection, focusing on the non-lytic escape mechanism known as vomocytosis. Infection with 259 either HIV or measles virus led to an enhancement in vomocytosis of C. neoformans, without 260 affecting uptake or intracellular proliferation of the fungus (Figure 1) , an effect that could be 261 recapitulated by stimulation with IFN and abrogated when signalling from type-I interferon 262 receptor was blocked (Figures 2 and 3) . Thus, viral coinfection stimulates expulsion of 263 intracellular fungi via Type I interferon signalling. 270 Infection with measles virus has been reported to induce limited production of type-I 271 interferons in macaque models, albeit with potent induction of interferon-stimulated genes (34, 272 35). To date, there is no direct correlation between measles infection and cryptococcosis.
273 However, given that both pathogens have a distinct respiratory phase it is possible that they 274 interact within this shared niche, potentially through low doses of antiviral signalling.
275
276 Why might antiviral signalling induce vomocytosis? One possibility is that vomocytosis serves 277 to "reset" phagocytes that have been unable to kill their prey, thus allowing them to serve a 278 useful purpose in phagocytosing other pathogens rather than remaining "unavailable". In that 279 context, a potent inflammatory signal such as IFN may serve to accelerate this process during 14 280 localised infection, returning macrophages to functionality faster than would otherwise occur.
281 The consequences of vomocytosis on disease progression, however, are likely to be highly 282 context dependent; in some settings, this may enable a more robust immune response, but in 283 others it may serve to inadvertently disseminate the fungus to distal sites. 
